Arcus Biosciences, Inc. Quarterly Operating Lease, Right-of-Use Asset in USD from Q4 2020 to Q4 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Arcus Biosciences, Inc. quarterly Operating Lease, Right-of-Use Asset history and growth rate from Q4 2020 to Q4 2023.
  • Arcus Biosciences, Inc. Operating Lease, Right-of-Use Asset for the quarter ending December 31, 2023 was $92M, a 8% decline year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2023 $92M -$8M -8% Dec 31, 2023 10-K 2024-02-21
Q4 2022 $100M -$5M -4.76% Dec 31, 2022 10-K 2024-02-21
Q3 2022 $102M +$66.5M +187% Sep 30, 2022 10-Q 2022-11-02
Q2 2022 $104M +$67.9M +188% Jun 30, 2022 10-Q 2022-08-03
Q1 2022 $103M +$90.7M +741% Mar 31, 2022 10-Q 2022-05-09
Q4 2021 $105M +$92.2M +722% Dec 31, 2021 10-K 2023-02-28
Q3 2021 $35.6M Sep 30, 2021 10-Q 2021-11-08
Q2 2021 $36.1M Jun 30, 2021 10-Q 2021-08-05
Q1 2021 $12.2M Mar 31, 2021 10-Q 2021-05-05
Q4 2020 $12.8M Dec 31, 2020 10-K 2022-02-23
* An asterisk sign (*) next to the value indicates that the value is likely invalid.